I'm bullish on UHS due to strong acute care market growth, driven by rising chronic disease prevalence and robust healthcare spending. UHS's financials are impressive, with Q1'25 net income up 21% and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results